{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:08:55Z","timestamp":1794373735215,"version":"4.9.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sorafenib is a widely used targeting drug for hepatocellular carcinoma (HCC) patients; however, sorafenib resistance poses a significant clinical challenge. Hypoxia and extracellular vesicles (EVs) induce vasculogenic mimicry (VM) which is linked to sorafenib resistance in HCC. Migrasomes (Migs), the newly discovered large EVs, foster HCC malignant phenotypes by facilitating the intercellular transfer of functional molecules. Despite these advancements, the precise mechanism by which Migs cause sorafenib resistance is still unknown. In this study, we found that hypoxia upregulates the Migs release and CD147 expression on Migs surface, which is related to sorafenib resistance in HCC. Further investigations revealed that hypoxia-induced migrasomes (hypo-Migs) induce VM formation, thereby promoting sorafenib resistance in HCC. Notably, hypo-Migs are internalized into HCC cells through macropinocytosis, which depends on the expression of lysophosphatidic acid receptor 6 (LPAR6). Mechanistically, CD147-positive (CD147\n                    <jats:sup>+<\/jats:sup>\n                    ) hypo-Migs activate the PI3K\/AKT\/TWIST1 signaling pathway, subsequently inducing VM formation and promoting sorafenib resistance. Importantly, dual blockade of CD147\n                    <jats:sup>+<\/jats:sup>\n                    -hypo-Migs macropinocytosis and VM formation enhances the sorafenib-killing efficacy to HCC. Conclusively, our findings uncover a novel sorafenib resistance mechanism induced by CD147\n                    <jats:sup>+<\/jats:sup>\n                    -hypo-Migs, and highlight dual-targeting of macropinocytosis and VM as a promising strategy to overcome the sorafenib resistance in HCC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08972-y","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:25:20Z","timestamp":1781529920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD147-positive migrasome macropinocytosis promotes HCC sorafenib resistance via inducing vasculogenic mimicry triggered by PI3K\/AKT\/TWIST1 signaling"],"prefix":"10.1038","volume":"17","author":[{"given":"Luomeng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3618-5292","authenticated-orcid":false,"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3564-1142","authenticated-orcid":false,"given":"Ran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-1993","authenticated-orcid":false,"given":"Sihe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"8972_CR1","doi-asserted-by":"crossref","unstructured":"Huang C, Li Y, Zhang F, Zhang C, Ding Z. Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma. Int J Surg. 2025;111:2990\u20133005.","DOI":"10.1097\/JS9.0000000000002294"},{"key":"8972_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","volume":"50","author":"C M\u00e9ndez-Blanco","year":"2018","unstructured":"M\u00e9ndez-Blanco C, Fondevila F, Garc\u00eda-Palomo A, Gonz\u00e1lez-Gallego J, Mauriz JL. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp Mol Med. 2018;50:1\u20139.","journal-title":"Exp Mol Med"},{"key":"8972_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2014.08.025","volume":"61","author":"GK Wilson","year":"2014","unstructured":"Wilson GK, Tennant DA, McKeating JA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J Hepatol. 2014;61:1397\u2013406.","journal-title":"J Hepatol"},{"key":"8972_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jhep.2021.12.028","volume":"76","author":"T Cramer","year":"2022","unstructured":"Cramer T, Vaupel P. Severe hypoxia is a typical characteristic of human hepatocellular carcinoma: Scientific fact or fallacy? J Hepatol. 2022;76:975\u201380.","journal-title":"J Hepatol"},{"key":"8972_CR5","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.7150\/thno.26789","volume":"8","author":"Z Liu","year":"2018","unstructured":"Liu Z, Wang Y, Dou C, Xu M, Sun L, Wang L, et al. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics. 2018;8:4649\u201363.","journal-title":"Theranostics"},{"key":"8972_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105507","volume":"166","author":"N Zheng","year":"2021","unstructured":"Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharm Res. 2021;166:105507.","journal-title":"Pharm Res"},{"key":"8972_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20:7.","journal-title":"Mol Cancer"},{"key":"8972_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107805","volume":"223","author":"L Treps","year":"2021","unstructured":"Treps L, Faure S, Clere N. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target. Pharm Ther. 2021;223:107805.","journal-title":"Pharm Ther"},{"key":"8972_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13:19.","journal-title":"J Hematol Oncol"},{"key":"8972_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1629865","volume":"8","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Yao X, Liu X, He X, Li L, Liu X, et al. Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles. 2019;8:1629865.","journal-title":"J Extracell Vesicles"},{"key":"8972_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-020-1529-9","volume":"39","author":"XY Huang","year":"2020","unstructured":"Huang XY, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39:20.","journal-title":"J Exp Clin Cancer Res"},{"key":"8972_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2014.135","volume":"25","author":"L Ma","year":"2015","unstructured":"Ma L, Li Y, Peng J, Wu D, Zhao X, Cui Y, et al. Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration. Cell Res. 2015;25:24\u201338.","journal-title":"Cell Res"},{"key":"8972_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41422-020-00415-3","volume":"31","author":"M Zhu","year":"2021","unstructured":"Zhu M, Zou Q, Huang R, Li Y, Xing X, Fang J, et al. Lateral transfer of mRNA and protein by migrasomes modifies the recipient cells. Cell Res. 2021;31:237\u201340.","journal-title":"Cell Res"},{"key":"8972_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-026-00893-4","volume":"14","author":"Z Guo","year":"2026","unstructured":"Guo Z, Wen Y, He Q, Zhu Z, Lin X, Goli MM, et al. Migrasome and cancer\u2014from cellular to clinical perspectives. Biomark Res. 2026;14:20.","journal-title":"Biomark Res"},{"key":"8972_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-024-03082-z","volume":"43","author":"K Zhang","year":"2024","unstructured":"Zhang K, Zhu Z, Jia R, Wang NA, Shi M, Wang Y, et al. CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis. J Exp Clin Cancer Res. 2024;43:160.","journal-title":"J Exp Clin Cancer Res"},{"key":"8972_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07485-0","volume":"23","author":"Y Luo","year":"2025","unstructured":"Luo Y, Huang Y, Huang Y, Chen L. Hypoxic migrasomes drive colorectal cancer liver metastasis by mediating CD5L(+) macrophage efferocytosis via NRP2\/PROX1 axis. J Transl Med. 2025;23:1384.","journal-title":"J Transl Med"},{"key":"8972_CR17","doi-asserted-by":"publisher","DOI":"10.34133\/research.0950","volume":"8","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Zhang K, Wu W, Zhou J, Zhang M, Chen J, et al. POSTN(+) CAF-derived migrasomes drive hepatocellular carcinoma progression and confer resistance to immunotherapy. Research. 2025;8:0950.","journal-title":"Research"},{"key":"8972_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114729","volume":"453","author":"L Pan","year":"2025","unstructured":"Pan L, Zhou R, Wen Z, Lin Y, Cai H, Lin C, et al. tsRNA-10105-enriched migrasomes mediate hepatocellular carcinoma immunosuppressive microenvironment by inducing M2 Macrophage polarization. Exp Cell Res. 2025;453:114729.","journal-title":"Exp Cell Res"},{"key":"8972_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s10495-025-02103-2","volume":"30","author":"W Chen","year":"2025","unstructured":"Chen W, Liu K, Wang Z, Zhang H, Tan M, Liu Y, et al. Migrasome-related ITGA5 for predicting prognosis, immune infiltration and drug sensitivity of hepatocellular carcinoma. Apoptosis. 2025;30:1424\u201339.","journal-title":"Apoptosis"},{"key":"8972_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/biomedicines13040773","volume":"13","author":"Z Yu","year":"2025","unstructured":"Yu Z, Luo J, An W, Wei H, Li M, He L, et al. Migrasome marker epidermal growth factor domain-specific O-GlcNAc transferase: Pan-Cancer angiogenesis biomarker and the potential role of circ_0058189\/miR-130a-3p\/EOGT axis in hepatocellular carcinoma progression and Sorafenib resistance. Biomedicines. 2025;13:773.","journal-title":"Biomedicines"},{"key":"8972_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1581122","volume":"16","author":"H Qin","year":"2025","unstructured":"Qin H, Qi T, Liu M, Sheng W, Qian J, Weng J, et al. A migrasome-related lncRNA signature predicts prognosis and immune response in hepatocellular carcinoma: implications for biomarker discovery and therapeutic targeting. Front Pharm. 2025;16:1581122.","journal-title":"Front Pharm"},{"key":"8972_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41422-025-01153-0","volume":"35","author":"J Yu","year":"2025","unstructured":"Yu J, Yu L. A decade of migrasome research: biogenesis, physiological functions, and disease implications. Cell Res. 2025;35:629\u201341.","journal-title":"Cell Res"},{"key":"8972_CR23","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1111\/febs.16756","volume":"290","author":"Y Ma","year":"2023","unstructured":"Ma Y, Li T, Zhao L, Zhou D, Dong L, Xu Z, et al. Isolation and characterization of extracellular vesicle-like nanoparticles derived from migrasomes. FEBS J. 2023;290:3359\u201368.","journal-title":"FEBS J"},{"key":"8972_CR24","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1002\/cam4.5110","volume":"12","author":"Y Shi","year":"2023","unstructured":"Shi Y, Shang J, Li Y, Zhong D, Zhang Z, Yang Q, et al. ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma. Cancer Med. 2023;12:3786\u201396.","journal-title":"Cancer Med"},{"key":"8972_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.drup.2008.04.002","volume":"11","author":"BP Toole","year":"2008","unstructured":"Toole BP, Slomiany MG. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat. 2008;11:110\u201321.","journal-title":"Drug Resist Updat"},{"key":"8972_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/B978-0-12-800092-2.00013-7","volume":"123","author":"GD Grass","year":"2014","unstructured":"Grass GD, Dai L, Qin Z, Parsons C. Toole BP. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance. Adv Cancer Res. 2014;123:351\u201373.","journal-title":"Adv Cancer Res"},{"key":"8972_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202518884","volume":"13","author":"XM Yang","year":"2026","unstructured":"Yang XM, Bian H, Chen ZN. CD147\/Basigin: from integrative molecular hub to translational therapeutic target. Adv Sci. 2026;13:e18884.","journal-title":"Adv Sci"},{"key":"8972_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.7150\/ijbs.125483","volume":"22","author":"L Qian","year":"2026","unstructured":"Qian L, Fu Z, Chen P, Guo Y, Li Y, Wang Y, et al. Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147(+) extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. Int J Biol Sci. 2026;22:220\u201338.","journal-title":"Int J Biol Sci"},{"key":"8972_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123213","volume":"319","author":"J Cui","year":"2025","unstructured":"Cui J, Zhang F, Jiang D, Liu B, Zhang H, Niu N, et al. An AIE-active near-infrared molecular probe for migrasome labeling. Biomaterials. 2025;319:123213.","journal-title":"Biomaterials"},{"key":"8972_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100849","volume":"64","author":"M Huang","year":"2022","unstructured":"Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, et al. New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects. Drug Resist Updat. 2022;64:100849.","journal-title":"Drug Resist Updat"},{"key":"8972_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153740","volume":"92","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang JG, Mu W, Zhou HM, Liu GL, Li Q. The role of daurisoline treatment in hepatocellular carcinoma: inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib. Phytomedicine. 2021;92:153740.","journal-title":"Phytomedicine"},{"key":"8972_CR32","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1158\/1535-7163.MCT-13-1060","volume":"13","author":"J Meng","year":"2014","unstructured":"Meng J, Sun B, Zhao X, Zhang D, Zhao X, Gu Q, et al. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma. Mol Cancer Ther. 2014;13:3107\u201322.","journal-title":"Mol Cancer Ther"},{"key":"8972_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103392","volume":"24","author":"Y Li","year":"2021","unstructured":"Li Y, Qiao K, Zhang X, Liu H, Zhang H, Li Z, et al. Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor. iScience. 2021;24:103392.","journal-title":"iScience"},{"key":"8972_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-0716-2403-6_11","volume":"2514","author":"S Imani","year":"2022","unstructured":"Imani S, Liu S, Maghsoudloo M, Wen Q. Histochemical staining of vasculogenic mimicry. Methods Mol Biol. 2022;2514:107\u201320.","journal-title":"Methods Mol Biol"},{"key":"8972_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12600","volume":"52","author":"HF Wang","year":"2019","unstructured":"Wang HF, Wang SS, Zheng M, Dai LL, Wang K, Gao XL, et al. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. Cell Prolif. 2019;52:e12600.","journal-title":"Cell Prolif"},{"key":"8972_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/cr.2011.144","volume":"22","author":"Q Qin","year":"2012","unstructured":"Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2012;22:90\u2013106.","journal-title":"Cell Res"},{"key":"8972_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101209","volume":"79","author":"L Qian","year":"2025","unstructured":"Qian L, Chen P, Zhang S, Wang Z, Guo Y, Koutouratsas V, et al. The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resist Updat. 2025;79:101209.","journal-title":"Drug Resist Updat"},{"key":"8972_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41568-025-00892-x","volume":"26","author":"D Tang","year":"2026","unstructured":"Tang D, Wang J, Kroemer G, Kang R. Targeting macropinocytosis for cancer therapy. Nat Rev Cancer. 2026;26:167\u201384.","journal-title":"Nat Rev Cancer"},{"key":"8972_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2017.09.019","volume":"266","author":"H Costa Verdera","year":"2017","unstructured":"Costa Verdera H, Gitz-Francois JJ, Schiffelers RM, Vader P. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Control Release. 2017;266:100\u20138.","journal-title":"J Control Release"},{"key":"8972_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13046-022-02296-3","volume":"41","author":"JK Byun","year":"2022","unstructured":"Byun JK, Lee S, Kang GW, Lee YR, Park SY, Song IS, et al. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:98.","journal-title":"J Exp Clin Cancer Res"},{"key":"8972_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/cl.23967","volume":"2","author":"D Dutta","year":"2012","unstructured":"Dutta D, Donaldson JG. Search for inhibitors of endocytosis: intended specificity and unintended consequences. Cell Logist. 2012;2:203\u20138.","journal-title":"Cell Logist"},{"key":"8972_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41580-025-00922-4","volume":"27","author":"L Ripoll","year":"2026","unstructured":"Ripoll L, Zickler AM, Vader P, El Andaloussi S, Verweij FJ, van Niel G. Biology and therapeutic potential of extracellular vesicle targeting and uptake. Nat Rev Mol Cell Biol. 2026;27:358\u201376.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8972_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trecan.2021.09.004","volume":"8","author":"J Puccini","year":"2022","unstructured":"Puccini J, Badgley MA, Bar-Sagi D. Exploiting cancer\u2019s drinking problem: regulation and therapeutic potential of macropinocytosis. Trends Cancer. 2022;8:54\u201364.","journal-title":"Trends Cancer"},{"key":"8972_CR44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","volume":"23","author":"B Banushi","year":"2023","unstructured":"Banushi B, Joseph SR, Lum B, Lee JJ, Simpson F. Endocytosis in cancer and cancer therapy. Nat Rev Cancer. 2023;23:450\u201373.","journal-title":"Nat Rev Cancer"},{"key":"8972_CR45","doi-asserted-by":"crossref","unstructured":"Imoto Y, Watanabe S. Beyond clathrin: decoding the mechanism of ultrafast endocytosis. Physiology. 2025;40:454\u201369.","DOI":"10.1152\/physiol.00041.2024"},{"key":"8972_CR46","doi-asserted-by":"publisher","first-page":"6461","DOI":"10.1158\/1078-0432.CCR-13-1284","volume":"19","author":"SC Su","year":"2013","unstructured":"Su SC, Hu X, Kenney PA, Merrill MM, Babaian KN, Zhang XY, et al. Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma. Clin Cancer Res. 2013;19:6461\u201372.","journal-title":"Clin Cancer Res"},{"key":"8972_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-025-02423-4","volume":"10","author":"R Nadhan","year":"2025","unstructured":"Nadhan R, Nath K, Basu S, Isidoro C, Song YS, Dhanasekaran DN. Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks. Signal Transduct Target Ther. 2025;10:337.","journal-title":"Signal Transduct Target Ther"},{"key":"8972_CR48","first-page":"1423","volume":"35","author":"D Millimaggi","year":"2009","unstructured":"Millimaggi D, Mari M, DA S, Giusti I, Pavan A, Dolo V. Vasculogenic mimicry of human ovarian cancer cells: role of CD147. Int J Oncol. 2009;35:1423\u20138.","journal-title":"Int J Oncol"},{"key":"8972_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2006.12.036","volume":"254","author":"S Zhang","year":"2007","unstructured":"Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett. 2007;254:157\u201364.","journal-title":"Cancer Lett"},{"key":"8972_CR50","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1038\/s41388-018-0261-9","volume":"37","author":"X Guo","year":"2018","unstructured":"Guo X, Qiu W, Liu Q, Qian M, Wang S, Zhang Z, et al. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten Pathways. Oncogene. 2018;37:4239\u201359.","journal-title":"Oncogene"},{"key":"8972_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-421","volume":"12","author":"HW King","year":"2012","unstructured":"King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012;12:421.","journal-title":"BMC Cancer"},{"key":"8972_CR52","first-page":"E3234","volume":"111","author":"T Wang","year":"2014","unstructured":"Wang T, Gilkes DM, Takano N, Xiang L, Luo W, Bishop CJ, et al. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 2014;111:E3234\u20133242.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8972_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13578-019-0325-8","volume":"9","author":"R Ren","year":"2019","unstructured":"Ren R, Sun H, Ma C, Liu J, Wang H. Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment. Cell Biosci. 2019;9:62.","journal-title":"Cell Biosci"},{"key":"8972_CR54","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.3390\/cancers13164176","volume":"13","author":"A G\u0142uszko","year":"2021","unstructured":"G\u0142uszko A, Szczepa\u0144ski MJ, Whiteside TL, Reichert TE, Siewiera J, Ludwig N. Small extracellular vesicles from head and neck squamous cell carcinoma cells carry a proteomic signature for tumor hypoxia. Cancers. 2021;13:4176.","journal-title":"Cancers"},{"key":"8972_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12310","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Wu R, Zhai P, Liu Z, Xia R, Zhang Z, et al. Hypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1A by HIF-1\u03b1. J Extracell Vesicles. 2023;12:e12310.","journal-title":"J Extracell Vesicles"},{"key":"8972_CR56","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41388-018-0189-0","volume":"37","author":"KDP Dorayappan","year":"2018","unstructured":"Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, et al. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins. Oncogene. 2018;37:3806\u201321.","journal-title":"Oncogene"},{"key":"8972_CR57","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.immuni.2019.01.010","volume":"50","author":"F Zhang","year":"2019","unstructured":"Zhang F, Li R, Yang Y, Shi C, Shen Y, Lu C, et al. Specific decrease in B-cell-derived extracellular vesicles enhances post-chemotherapeutic CD8(+) T cell responses. Immunity. 2019;50:738\u201350.e737.","journal-title":"Immunity"},{"key":"8972_CR58","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/mc.22124","volume":"54","author":"A Ramteke","year":"2015","unstructured":"Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A, et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog. 2015;54:554\u201365.","journal-title":"Mol Carcinog"},{"key":"8972_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.actbio.2019.12.020","volume":"103","author":"W Liu","year":"2020","unstructured":"Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z, et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2020;103:196\u2013212.","journal-title":"Acta Biomater"},{"key":"8972_CR60","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1541-7786.MCR-19-0725","volume":"18","author":"J Li","year":"2020","unstructured":"Li J, Yuan H, Xu H, Zhao H, Xiong N. Hypoxic cancer-secreted exosomal miR-182-5p promotes glioblastoma angiogenesis by targeting Kruppel-like factor 2 and 4. Mol Cancer Res. 2020;18:1218\u201331.","journal-title":"Mol Cancer Res"},{"key":"8972_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-017-0533-1","volume":"36","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu F, et al. HIF-1\u03b1 promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res. 2017;36:60.","journal-title":"J Exp Clin Cancer Res"},{"key":"8972_CR62","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.24543","volume":"54","author":"T Sun","year":"2011","unstructured":"Sun T, Sun BC, Zhao XL, Zhao N, Dong XY, Che N, et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology. 2011;54:1690\u2013706.","journal-title":"Hepatology"},{"key":"8972_CR63","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1007\/s12032-010-9706-x","volume":"28","author":"WB Liu","year":"2011","unstructured":"Liu WB, Xu GL, Jia WD, Li JS, Ma JL, Chen K, et al. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Med Oncol. 2011;28:S228\u2013238.","journal-title":"Med Oncol"},{"key":"8972_CR64","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hep.23311","volume":"51","author":"T Sun","year":"2010","unstructured":"Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51:545\u201356.","journal-title":"Hepatology"},{"key":"8972_CR65","doi-asserted-by":"publisher","first-page":"436","DOI":"10.7150\/thno.90322","volume":"14","author":"LN Qin","year":"2024","unstructured":"Qin LN, Zhang H, Li QQ, Wu T, Cheng SB, Wang KW, et al. Vitamin D binding protein (VDBP) hijacks Twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma. Theranostics. 2024;14:436\u201350.","journal-title":"Theranostics"},{"key":"8972_CR66","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","volume":"18","author":"DA Kirschmann","year":"2012","unstructured":"Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res. 2012;18:2726\u201332.","journal-title":"Clin Cancer Res"},{"key":"8972_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cytogfr.2021.10.006","volume":"62","author":"AK Herrera-Vargas","year":"2021","unstructured":"Herrera-Vargas AK, Garc\u00eda-Rodr\u00edguez E, Olea-Flores M, Mendoza-Catal\u00e1n MA, Flores-Alfaro E, Navarro-Tito N. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev. 2021;62:23\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"key":"8972_CR68","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.2147\/OTT.S271891","volume":"13","author":"R Cheng","year":"2020","unstructured":"Cheng R, Wang B, Cai XR, Chen ZS, Du Q, Zhou LY, et al. CD276 Promotes vasculogenic mimicry formation in hepatocellular carcinoma via the PI3K\/AKT\/MMPs pathway. Onco Targets Ther. 2020;13:11485\u201398.","journal-title":"Onco Targets Ther"},{"key":"8972_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, et al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and Challenges. Pharm Res. 2023;187:106553.","journal-title":"Pharm Res"},{"key":"8972_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115455","volume":"167","author":"J Huang","year":"2023","unstructured":"Huang J, Wang C, Hou Y, Tian Y, Li Y, Zhang H, et al. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K\/AKT\/mTOR signaling pathway. Biomed Pharmacother. 2023;167:115455.","journal-title":"Biomed Pharmacother"},{"key":"8972_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105195","volume":"160","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang Y, Qin X, Geng H, Zuo D, Zhao Q. PI3K\/AKT\/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharm Res. 2020;160:105195.","journal-title":"Pharm Res"},{"key":"8972_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78464-2","volume":"10","author":"S Kanno","year":"2020","unstructured":"Kanno S, Hirano S, Sakamoto T, Furuyama A, Takase H, Kato H, et al. Scavenger receptor MARCO contributes to cellular internalization of exosomes by dynamin-dependent endocytosis and macropinocytosis. Sci Rep. 2020;10:21795.","journal-title":"Sci Rep"},{"key":"8972_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12426","volume":"13","author":"X Lu","year":"2024","unstructured":"Lu X, Song Z, Hao J, Kong X, Yuan W, Shen Y, et al. Proton pump inhibitors enhance macropinocytosis-mediated extracellular vesicle endocytosis by inducing membrane v-ATPase assembly. J Extracell Vesicles. 2024;13:e12426.","journal-title":"J Extracell Vesicles"},{"key":"8972_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70025","volume":"13","author":"B Zhang","year":"2024","unstructured":"Zhang B, Chen J, Chen J, Shen Y, Chen Y, Wang S, et al. CD7-targeting pro-apoptotic extracellular vesicles: A novel approach for T-cell haematological malignancy therapy. J Extracell Vesicles. 2024;13:e70025.","journal-title":"J Extracell Vesicles"},{"key":"8972_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/cac2.12515","volume":"44","author":"Y Yao","year":"2024","unstructured":"Yao Y, Xu Y, Yu L, Xue TM, Xiao ZJ, Tin PC, et al. NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma. Cancer Commun. 2024;44:251\u201372.","journal-title":"Cancer Commun"},{"key":"8972_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02676-1","volume":"22","author":"Y Shi","year":"2024","unstructured":"Shi Y, Chen Y, Wang Y, Mo D, Ai H, Zhang J, et al. Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors. J Nanobiotechnology. 2024;22:447.","journal-title":"J Nanobiotechnology"},{"key":"8972_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12091","volume":"10","author":"D Choi","year":"2021","unstructured":"Choi D, Montermini L, Meehan B, Lazaris A, Metrakos P, Rak J. Oncogenic RAS drives the CRAF-dependent extracellular vesicle uptake mechanism coupled with metastasis. J Extracell Vesicles. 2021;10:e12091.","journal-title":"J Extracell Vesicles"},{"key":"8972_CR78","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.7150\/thno.47996","volume":"11","author":"C Tu","year":"2021","unstructured":"Tu C, Du Z, Zhang H, Feng Y, Qi Y, Zheng Y, et al. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells. Theranostics. 2021;11:2364\u201380.","journal-title":"Theranostics"},{"key":"8972_CR79","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/onc.2010.517","volume":"30","author":"SY Park","year":"2011","unstructured":"Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351\u20139.","journal-title":"Oncogene"},{"key":"8972_CR80","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-24-4501","volume":"86","author":"RA Burge","year":"2025","unstructured":"Burge RA, Bialousow L, Linke AJ, Coalson HS, Adair SJ, Sundararaj K, et al. PTEN oxidation promotes constitutive PI3K signaling and inducible macropinocytosis in pancreatic cancer. Cancer Res. 2025;86:1854\u201367.","journal-title":"Cancer Res"},{"key":"8972_CR81","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/2159-8290.CD-19-1006","volume":"10","author":"GA Hobbs","year":"2020","unstructured":"Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, et al. Atypical KRAS(G12R) mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer. Cancer Discov. 2020;10:104\u201323.","journal-title":"Cancer Discov"},{"key":"8972_CR82","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/cancers11111626","volume":"11","author":"E Kaffe","year":"2019","unstructured":"Kaffe E, Magkrioti C, Aidinis V. Deregulated lysophosphatidic acid metabolism and signaling in liver cancer. Cancers. 2019;11:1626.","journal-title":"Cancers"},{"key":"8972_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.922945","volume":"12","author":"S She","year":"2022","unstructured":"She S, Zhang Q, Shi J, Yang F, Dai K. Roles of autotaxin\/autotaxin-lysophosphatidic acid axis in the initiation and progression of liver cancer. Front Oncol. 2022;12:922945.","journal-title":"Front Oncol"},{"key":"8972_CR84","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/0008-5472.CAN-14-1607","volume":"75","author":"A Mazzocca","year":"2015","unstructured":"Mazzocca A, Dituri F, De Santis F, Filannino A, Lopane C, Betz RC, et al. Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma. Cancer Res. 2015;75:532\u201343.","journal-title":"Cancer Res"},{"key":"8972_CR85","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biochi.2022.07.016","volume":"202","author":"D Gnocchi","year":"2022","unstructured":"Gnocchi D, Kurzyk A, Mintrone A, Lentini G, Sabb\u00e0 C, Mazzocca A. Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma. Biochimie. 2022;202:180\u20139.","journal-title":"Biochimie"},{"key":"8972_CR86","doi-asserted-by":"crossref","unstructured":"Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, Huang W, et al. HAb18G\/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology. 2011;54:2012\u201324.","DOI":"10.1002\/hep.24592"},{"key":"8972_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1709-8","volume":"10","author":"S Qi","year":"2019","unstructured":"Qi S, Su L, Li J, Zhao P, Zhang Q, Niu X, et al. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle. Cell Death Dis. 2019;10:462.","journal-title":"Cell Death Dis"},{"key":"8972_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.512","volume":"5","author":"FZ Qi","year":"2024","unstructured":"Qi FZ, Su HS, Wang B, Qian LM, Wang Y, Wang CH, et al. Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity. MedComm. 2024;5:e512.","journal-title":"MedComm"},{"key":"8972_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01530-6","volume":"20","author":"L Su","year":"2022","unstructured":"Su L, Sun Z, Qi F, Su H, Qian L, Li J, et al. GRP75-driven, cell-cycle-dependent macropinocytosis of Tat\/pDNA-Ca(2+) nanoparticles underlies distinct gene therapy effect in ovarian cancer. J Nanobiotechnology. 2022;20:340.","journal-title":"J Nanobiotechnology"},{"key":"8972_CR90","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.7150\/ijbs.71571","volume":"18","author":"J Li","year":"2022","unstructured":"Li J, Qi F, Su H, Zhang C, Zhang Q, Chen Y, et al. GRP75-faciliated mitochondria-associated ER membrane (MAM) integrity controls cisplatin-resistance in ovarian cancer patients. Int J Biol Sci. 2022;18:2914\u201331.","journal-title":"Int J Biol Sci"},{"key":"8972_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1039-2","volume":"9","author":"X Niu","year":"2018","unstructured":"Niu X, Su L, Qi S, Gao Z, Zhang Q, Zhang S. GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway. Cell Death Dis. 2018;9:971.","journal-title":"Cell Death Dis"},{"key":"8972_CR92","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.2147\/IJN.S171361","volume":"13","author":"X Niu","year":"2018","unstructured":"Niu X, Gao Z, Qi S, Su L, Yang N, Luan X, et al. Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat\/pDNA nano-complexes into ovarian cancer cells. Int J Nanomed. 2018;13:4895\u2013911.","journal-title":"Int J Nanomed"},{"key":"8972_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409870","volume":"12","author":"W Liu","year":"2025","unstructured":"Liu W, Li L, Bai X, Zhang M, Lv W, Ma Y, et al. Osteosarcoma cell-derived migrasomes promote macrophage M2 polarization to aggravate osteosarcoma proliferation and metastasis. Adv Sci. 2025;12:e2409870.","journal-title":"Adv Sci"},{"key":"8972_CR94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41421-019-0093-y","volume":"5","author":"X Zhao","year":"2019","unstructured":"Zhao X, Lei Y, Zheng J, Peng J, Li Y, Yu L, et al. Identification of markers for migrasome detection. Cell Discov. 2019;5:27.","journal-title":"Cell Discov"},{"key":"8972_CR95","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.actbio.2023.12.020","volume":"175","author":"N Song","year":"2024","unstructured":"Song N, Sun Z, Wang B, Liu X, Hu B, Chen N, et al. Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy. Acta Biomater. 2024;175:250\u201361.","journal-title":"Acta Biomater"},{"key":"8972_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1114-z","volume":"18","author":"X Wang","year":"2019","unstructured":"Wang X, Qiao D, Chen L, Xu M, Chen S, Huang L, et al. Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance. Mol Cancer. 2019;18:182.","journal-title":"Mol Cancer"},{"key":"8972_CR97","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.7150\/ijbs.92211","volume":"20","author":"B Wang","year":"2024","unstructured":"Wang B, Qi FZ, Chen P, Qian LM, Su HS, Wang Y, et al. Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma. Int J Biol Sci. 2024;20:1634\u201351.","journal-title":"Int J Biol Sci"},{"key":"8972_CR98","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s13046-019-1464-9","volume":"38","author":"S Qi","year":"2019","unstructured":"Qi S, Su L, Li J, Zhang C, Ma Z, Liu G, et al. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes. J Exp Clin Cancer Res. 2019;38:471.","journal-title":"J Exp Clin Cancer Res"},{"key":"8972_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102146","volume":"6","author":"T Xia","year":"2025","unstructured":"Xia T, Yin H, Zhu Q, Zhang K, Xie H, Shan Y, et al. DDX5 super-enhancer promotes vasculogenic mimicry formation and metastasis in nasopharyngeal carcinoma by enhancing ADAM10 transcription. Cell Rep Med. 2025;6:102146.","journal-title":"Cell Rep Med"},{"key":"8972_CR100","doi-asserted-by":"publisher","DOI":"10.34133\/research.0998","volume":"8","author":"S Wu","year":"2025","unstructured":"Wu S, Yao C, Fang L, Sun Y, Zhao M, Chen J, et al. ATPase inhibitory factor 1 drives mitochondrial energy metabolic reprogramming to promote HCC vasculogenic mimicry via the ESR1\/miR-20a-3p\/GNAZ pathway. Research. 2025;8:0998.","journal-title":"Research"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08972-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:04:46Z","timestamp":1787569486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08972-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8972"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08972-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Nankai University Animal Care and Use Committee (approval number: 2021-SYDWLL-000479). The usage of clinical blood and tissue specimens was approved by the Review and Ethics Board of Nankai University (approval number: NKUIRB2021043). Informed consent was obtained from all participants and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"750"}}